Enzyre is a UMC St. Radboud spin-off company which officially started in March 2017. It was founded with the mission to develop innovative diagnostic solutions to enable personalized medicine. The company holds the vision to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.
